The arrival of Retatrutide in the United Kingdom is creating significant excitement within the obesity community. This groundbreaking dual medication – targeting both GLP-1 and GIP – promises a remarkably new solution to combating excess weight . Until recently, options have been limited for many, and Retatrutide represents a promising possibil